A B S T R A C T In these experiments we investigated whether NAD could serve as an intracellular modulator of the brush border membrane (BBM) transport of inorganic phosphate (Pi). NAD, both oxidized (NAD+) and reduced (NADH) form, inhibited the Na+-dependent uptake of 32Pi in the concentration range of 10-300 zM NAD when added in vitro to BBM vesicles isolated from rat kidney cortex, but did not inhibit BBM uptake of D-[3H]glucose or BBM uptake of 22Na+. Neither nicotinamide (NiAm) nor adenosine alone influenced BBM uptake of 32Pi. NAD had a similar relative effect (percent inhibition) in BBM from rats stabilized on low Pi diet (0.07% Pi), high Pi diet (1.2% Pi), or normal Pi diet (0.7% Pi).
INTRODUCTION
A Na+-dependent Pi uptake by the luminal brush border membrane (BBM) and its regulation by various hormonal and metabolic stimuli (1-3) are initial and perhaps quantitatively determining cellular steps in proximal tubular reabsorption of phosphate (Pi). Parathyroid hormone (PTH) or vitamin D (1, 3) has been reported to decrease BBM uptake ofPi, whereas growth hormone reportedly has an opposite effect (4) . In phosphaturia associated with starvation (5) or a high Pi diet (2) , the capacity of the BBM to transport Pi is diminished; feeding with a diet selectively deficient in Pi, however, leads to a marked increase in BBM uptake of Pi (1) (2) (3) 5) , which is apparently independent of the regulatory actions of PTH, calcitonin, thyroid hormones, or vitamin D (1) (2) (3) .
Very little is known about the biochemical mechanisms by which the BBM is modulated to transport Pi. It is assumed that the effect of PTH on BBM uptake of Pi is mediated by cyclic (c)AMP, since the in vivo injection of N6,02-dibutyryl cyclic AMP (DBcAMP) resulted in decreased BBM uptake of Pi (1) . However, cAMP added directly to the BBM vesicles in vivo had no effect on the BBM uptake of Pi (1, Kempson and Dousa, unpublished observations). Prominent changes in the rate of BBM uptake of Pi caused by variation of the dietary Pi intake (1, 2) or by starvation (5) , seem to occur independently of the regulatory influence of cAMP (1, 6, 7) . Thus, although cAMP may indeed play a role in the actions of some phosphaturic hormones (e.g., PTH, calcitonin) (8) , the intracellular factors which regulate the rate of Pi transport across BBM of proximal tubules in response to various pathophysiologic states remain to be identified (8) .
Alkaline phosphatase (AlPase), localized in luminal BBM, was suggested to play some role, direct or indirect, in BBM transport of Pi (2) . In many instances the AlPase activity in BBM changes in parallel with the rate of BBM transport of Pi (2) , and in vivo administration of AlPase inhibitors was reported to reduce renal Pi reabsorption (9) ; however, the potential involvement of AlPase in BBM transport of Pi remains controversial (1, 2) . A recent report (10) that NAD inhibits AlPase extracted from hog kidney deserves special attention. NAD is a naturally occurring nucleotide and serves as a coenzyme of diverse dehydrogenases (11) in numerous oxidation-reduction reactions at various steps of mammalian intermediary metabolism, though mainly in cytoplasm. In addition, NAD plays a role in biochemical processes unrelated to the redox reactions; e.g., intracellular NAD+ (the oxidized form of NAD) is the source for ADP-ribosylation of plasma membrane proteins (12) .
The NAD+/NADH ratio depends on the metabolic status of the cell and is higher in cytoplasm than in mitochondria (13) ; the predominant form of NAD in the cytoplasm is NAD+ (13) . Moreover, NAD+ is less tightly bound to dehydrogenases, compared with NADH (14) ; it is thus conceivable that free NAD+ in the cytoplasm (cytosol) could interact with at least some proteins, e.g., AlPase, in the luminal BBM. Based on these premises, we considered and tested the hypothesis that NAD acts on renal luminal BBM and thereby regulates the rate of Pi transport across this membrane. in all experiments and were allowed unlimited access to distilled water. Rats that had been surgically thyroparathyroidectomized (TPTX), as indicated in the text, were given water supplemented with calcium as described (15) . For collection of urine, the rats were housed individually in metabolic cages (5, 15) . Unless stated otherwise, all animals were fed regular rat diet (Purina Laboratory Chow, Ralston Purina Co., St. Louis, Mo.) containing 0.7% Pi. High phosphorus diet (HPD) contained 1.2% Pi and was prepared by Pi supplementation of commercial low phosphorus diet (LPD) containing 0.07% Pi (ICN Pharmaceuticals Inc., Life Sciences Group, Cleveland, Ohio), as described in detail (5, 16) . HPD and LPD rats, when compared, were placed simultaneously on the different diets, were pair-fed, and were monitored, sacrificed, and analyzed simultaneously as described in detail (5, 15, 16) .
GLOSSARY OF TERMS
Experiments with acute effects of nicotinamide. Nicotinamide (NiAm) dissolved in 0.6 ml of isotonic saline (pH adjusted to 7.0 with NaOH) was administered as a single intraperitoneal injection to rats kept in metabolic cages. Control animals were injected with the same volume of saline vehicle. In some experiments, urine was collected for at least 12 h prior to injection of NiAm or vehicle. After injection in all experiments, urine was collected for 9 h; then the rats were anesthetized with ethyl ether, venous blood was drawn, the kidneys were removed, and the renal cortex was dissected rapidly free from the medulla. Part of the renal cortical tissue was snap-frozen (within 30 s after removal of kidneys from the animal) by clamping between stainless steel tongs precooled in liquid nitrogen (17) , and the frozen tissue was stored in a liquid nitrogen freezer until extraction and analysis. The remaining cortical tissue was placed immediately in ice-cold solution (154 mM NaCl, 1 mM TrisHepes; pH 7.5) and was used for preparation of a BBM fraction.
Preparation of a BBM fraction and transport measurements. BBM fractions were prepared from homogenized rat renal cortex by the calcium precipitation procedure described in detail in our previous studies on rats (5, 15) . Verification of' the identity and purity of the BBM vesicle fraction used for transport studies was described in full detail previously (5, 15) . In experiments where BBM was prepared from kidneys of one rat, to obtain a sufficient amount of BBM for transport studies particular care was paid to recover all BBM material in the course of preparation. For studies in vitro of the effects of NAD and other tested compounds on transport, isolated BBM vesicles suspended in 300 mM mannitol, 5 mM Tris-Hepes (pH 8.5), were preincubated for 30 min at 20°C in the absence (controls) or in the presence of the test compound. In the subsequent period of actual measurement of BBM uptake, the test compound was included in the incubation medium at the same concentration as used for preincubation. Uptake of 32P-phosphate and D-[3H]glucose by isolated BBM vesicles was measured by the Millipore filtration tech-nii(Iue (3, 5, 15) tised aind described in detail in otur previouis stud(lies (5, 15, 16) . Final concentrations of 32Pi and D-[3H]-glucose were 0.1 and 0.05 mM, respectively. Uptake was terminated by rapid addition of ice-cold stopping solution (135 mM NaCl, 10 mM sodium arsenate, 5 mM Tris-Hepes, pH 8.5) followed by filtration (5, 15) . Uptake of 22Na' was determined (in the absence of Pi or D-glucose) by an identical procedure; the incubation medium contained buffered 100 mM mannitol (pH 8.5), 100 mM 22NaCl (-4 x 105 cpm/ ttube). Uptake of 22Na' had fast onset (within 5 min it reached 103 nmol 22Na+/mg protein), followed by slower increase (154 nmol 22Na+/mg protein at 90 min). The stopping solution for 22Na' uptake was 150 mM MgSO4, 5 mM Tris-Hepes (pH 8.5) (18) . In each BBM preparation the uptake was measured in triplicate at each time period. All solutions uised for the preparation of BBM fractions and for transport measuiremiienits were filtered throuigh a 0.45 ,um Millipore filter on the day of utse (5, 15) .
Determiinationt of nuticleotides in renal tisstue. Acidic and alkaline extracts of' snap-frozen cortical tissue were prepared by the methods described by Klingenberg (19) . Briefly, -100-200 mg of the tissue was powdered while still f'rozen in liquiid nitrogen and extracted with either 0.6 N HCl04 (acid extract) at a ratio of 5:1 (HClO4:tisstie; wt/ wt) or with alcoholic 0.5 N KOH (alkaline extract) at a ratio of 10:1 (KOH:tisstue; wt/wt). After neuitralizationi followed by centrif'uigation to remove proteins, the clear extracts were assayed immilediately for content of NAD+, ATP (acid extract), and NADH (alkaline extract). A sample of f'rozen renal cortex (100 mg) was deproteinized with 5 ml of ice-cold 5% TCA and was processed for determination of the cAMP level by the procedure for renal cortical tissue described in recent studies from this laboratory (20) .
Fractionation of renal cortical tissue. In sttudies on the stubcellular distribution of NAD+ in rat renal cortex a 10% (wt/ vol) homogenate of cortical tissue was prepared -using five passes of a motor-driven glass-teflon homogenizer. The homogenization meditum was 0.25 M sucrose, 5 mM Tris-HCI (pH 7.4), containing 50 mM NiAm to inhibit enzymatic degradation of NAD+ (21, 22) . Part of the homogenate was extracted immediately with TCA (22) , while the remainder was centrifuged for 60 min at 105 g. The restulting supernate (cytosol fraction) and pellet (particulate fraction) were separated and extracted immediately with TCA (22) . After centrifuging the extracts to remove denatured protein, the TCA was removed by several washes with 3 vol of watersaturated ether (22) . The pH of the washed extracts was adjusted to neutrality and the NAD+ content was determined the same day. All steps in the fractionation and extraction procedure were performed at 0°-4°C.
Assays. cAMP was assayed by radioimmunoassay as described in our previous study (20) ; recoveries of cAMP ranged between 80 and 90%.
Assays for NAD+ and NADH were based on the interconversion of lactate and pyruvate catalyzed by lactate dehydrogenase and requiring NAD (19) . The final volume of the reaction mixtures was 2.0 ml, and the reactions were started by addition of 0.005 ml of lactate dehydrogenase (3,000 U/ ml). The The reaction medium for NADH measurement contained 0.15 mM pyruvate, 0.1 M sodium phosphate buffer (pH 7.5), and up to 0.1 ml of alkaline extract or standard NADH solution. After incubation for 17 min at 37°C, the decrease in fluorescence was linear in the range of 1-10 nmol of NADH.
ATP was determined from fluorimetric measurement of NADPH using the hexokinase and glucose 6-phosphate dehydrogenase method (23) . The final reaction mixture (total volume 2.0 ml) contained 10 mM D-glucose, 5 ,uM NADP, 1.5 mM MgCl2, 0.6 mM EDTA, 12.5 mM triethanolamine HCI (pH 8.0), and up to 0.1 ml of the acid extract or standard ATP solution. The reaction was started by addition of 0.01 ml of glucose 6-phosphate dehydrogenase (125 U/ml) and 0.03 ml of hexokinase (132 U/ml). After 15 min at 37°C, the increase in fluorescence (excitation at 365 nm, emission at 460 nm) was proportional to the amount of ATP in the range of 0-15 nmol. If nucleotide content is expressed per tissue water, concentrations would be higher; however, tissue levels of NAD and ATP are expressed per wet weight as in most other reports (19, 22) .
AlPase was assayed in principle as described previously (15, 16) , at 20°C, pH 8.5, and using p-nitrophenyl phosphate as substrate in a medium identical to that used for the Pi transport studies (16) . Plasma and urine content of Pi was measured by the method of Chen et al. (24) , and plasma and urine creatinine (Cr) were determined colorimetrically (25) . calcium (Ca) in plasma and urine samples was measured by an atomic absorption spectrophotometer (Perkin Elmer Corp., Norwalk, Conn., model 303), and sodium (NA+) and potassium (K+) were determined by flame photometry (Instrumentation Laboratory Inc., Lexington, Mass., model 143) as in previous studies (15, 26) . Protein was determined by the method of Lowry et al. (27) after solubilization of the samples in 1% sodium lauryl sulfate, as in our previous studies (5, 15) .
In preliminary experiments, we determined that neither Basically, in experiments examining the effect of the addition of NAD and other agents in vitro (time-course, concentration-dependence), replicate assays were done on BBM prepared from pooled renal cortex of several kidneys. Therefore, Tables I-III and Fig. 1 represent data from different experiments; each of these experiments used on BBM preparation from the pooled renal cortices of 5-6 rats, and in each experiment the measurements were made in triplicate; experiments were done more than once. All data presented in Tables II, IV , V, and VII, and in Fig. 2 Closed symbols ( -0) represent the 32Pi uptake by BBM when NaCl in the incubation medium was replaced by 100 mM KCI (Na+-independent Pi uptake). Na+-independent uptake of 32Pi in the absence of NAD+, or measured in the presence of 30 In vitro studies. The major portion of32Pi uptake by renal cortical BBM vesicles was dependent on the presence of a transmembrane Na+ gradient (1, 2, 5, 15), and the uptake reached a maximum within 1-2 min ( Fig. 1) , the "overshoot" phase (1, 5, 15) . Addition of 30 AM NAD+ to isolated BBM vesicles caused a marked decrease in Na+-dependent 32Pi uptake in the whole "overshoot" phase, and this effect was even more pronounced with 300 yM NAD+ (Fig. 1) . In subsequent experiments, 32Pi uptake was measured in the initial "uphill" phase, at time intervals <1 min. Inhibition of Na+-dependent BBM uptake of 32Pi by NAD+ was dose dependent; in the concentration range 10-300 ,M NAD+, there was a progressive decrease in the initial 32Pi uptake, and at 300 ,uM NAD+ the inhibition reached was -50% (Table I) . Increasing the NAD+ concentration above 300 ,uM produced no furtlher inhibition of 32Pi uptake. NADH, the reduced form of NAD, (Tables I and II) , NiAm or adenosine in equimolar concentrations (30 or 300 uM) had no effect on the rate of initial Na+-dependent transport of 32Pi across BBM vesicle isolated from the renal cortex (data not shown). Effect of NAD stereoisomer, a-NAD (28), was compared with that of,B-NAD under the same conditions and in the same concentrations (30 and 300 ,uM). The Na+-dependent BBM uptake of 32Pi was inhibited to similar extents by equimolar concentrations of a-NAD+ and natural nucleotide /8-NAD (data not shown).
The inhibitory effect of NAD Pi transport was examined in the BBM preparation from kidneys of rats fed either LPD or HPD, which differ markedly in the rate of BBM uptake of Pi (16) . In BBM prepared from both LPD rats and HPD rats, NADH elicited a similar dose-dependent inhibition of BBM uptake of 32Pi, but had no effect on uptake of D-[3H]glucose (Table II) . Although the relative degree of32Pi transport inhibition by NAD, compared with that of controls, was similar in BBM vesicles from both LPD and HPD groups, reaching a maximum inhibition of about 50% (Table II) , the net decrease in the rate of 32Pi uptake caused by equimolar NAD concentrations was markedly greater in BBM vesicles with a high rate of32Pi transport prepared from LPD rats (Table II) . Inhibitory potency of NAD is, on a molar basis, comparable to inhibition of32Pi uptake by arsenate (Table III) , a known inhibitor of BBM transport of Pi (1, 16 LPD or HPD rats (Table II) is not due to some unusual insensitivity of the tested BBM preparations to inhibitors, since phlorizin, a specific inhibitor of Dglucose transport (29) elicited an expected inhibitory effect (Table II) . These in vitro results suggested that the inhibitory effect of NAD was specific for the Na+-dependent component of the Pi transport system in renal BBM, and that the effect was due to direct interaction of NAD with the isolated BBM. In vivo studies. Administration of large doses of NiAm, an NAD precursor (21, 22, 28) , resulted in an increased level of NAD (mainly NAD+) in the kidney (21, 30) and other tissues (21, 22, 28 Table   IV ). Each bar represents mean±SE of the same animals as in Table IV . The uptake was measured in the presence of a Na+ gradient in the "overshoot" phase (time intervals 15-30 s) of the uptake; final concentration of 32Pi was 0.1 mM, and that ofn-(3H]glucose, 0.05mM (see Methods). *, Values significantly (P < 0.001; t test, n = 3) different from controls at the same time interval.
dose of NiAm was employed to increase the level of NAD+ in renal tissue in vivo. Rats were stabilized on LPD and were kept in metabolic cages for collection of urine samples from control and post-NiAm injection periods, as described in Methods. After the control period, the rats were given an intraperitoneal injection of NiAm (1 g/kg body wt), and the urine was collected for an additional 9 h. In rats injected with NiAm, the content of NAD+ in the renal cortex markedly increased (Table IV) , and the rate of 32Pi uptake by BBM vesicles prepared from kidneys of the same NiAm-treated rats was mark- After a control period of 14 h rats were given an intraperitoneal injection of either NiAm (1 g/kg body wt) or vehicle solution. Urine was collected 9 h after injection, then the rats were killed. Part of the renal cortex was taken for determination of NAD+; the rest of the renal cortex was used for the BBM preparation employed in transport measurements, the results of which are portrayed in Fig. 2 (Fig. 2) . In addition, injection of NiAm caused a dramatic 100-200-fold increase in urinary excretion of Pi, compared with the control period or with the vehicle-injected rats (Table IV) . Specificity in terms of electrolyte excretion and reversibility of the phosphaturic effect of NiAm were explored in the following experiment. Rats were stabilized on LPD, urine was collected at 24-h periods, and urinary excretion of Pi (UpiV), sodium (UNaV), potassium (UKV), calcium (UcaV) and creatinine (UcrV) was monitored daily (Table V) . Injection of NiAm caused a huge increase in UpiV and some increase in urine flow; there were no differences between control and NiAminjected rats in UcrV and UKV; on the other hand, UcaV and UNaV decreased (Table V) . NiAm injection did not cause glycosuria. On the day after NiAm injection (day 3), Up1V returned to a level that was not significantly different either from UpV in the same rats before NiAm injection (day 1) or from UpjV in the control rats on day 3 (Table V) . In a control experiment using the same design as that described in Table IV , the effect of NiAm on plasma creatinine (PCr), plasma Pi (Pp1), and plasma calcium (Pca) was determined. NiAminjected rats with marked phosphaturia (UpjV was more than 40 times higher than in controls) did not differ significantly from vehicle-treated controls in Pp; Table IV . The rate of Na+-dependent 32Pi transport in BBM isolated from the kidney cortex of NiAminjected animals declined, and the extent of this decrease was more pronounced with higher doses of NiAm (Table VI) . In contrast, there were no differences between control and NiAm-treated animals in BBM uptake of 32Pi in the absence of a Na+ gradient (when NaCl in the incubation medium was replaced by KCI) measured in the same BBM preparation in which Na+-dependent 32Pi uptake was decreased. In BBM vesicles from NiAm-injected rats, the Na+-dependent and Na+-independent (KCI medium) uptake of D-[3H]glucose and the uptake of 22Na+ did not differ significantly from the controls (Table VI) . Injection of NiAm also caused elevation of the tissue NAD+ level, and the extent of the NAD+ increase was basically proportional to the dose of injected NiAm (Table VI) . Renal cortical NADH content increased after injection of 0.5 or 1.0 g/kg NiAm but to a much lesser extent than the increase in NAD+. This increase in NADH, although statistically significant, was relatively minor (maximum change, 45%) compared with the increase in NAD+ (maximum change, 290%). Consequently, the tissue NAD+/NADH ratio progressively increased from 2.4 to 6.4 in response to NiAm injection (Table VI) . Tissue levels of ATP and of cAMP were determined in aliquots of the same cortical tissue samples in which NAD+ and NADH were measured, and showed no difference between control rats and rats injected with NiAm (Table VI) .
The rate ofthe Na+-dependent uptake of32Pi by BBM vesicles was inversely proportional to both the increase in renal cortical content of NAD+ (r = -0.77+0.10; (Table VII) was significantly (P < 0.05) higher than in TPTX rats kept on LPD (Table VI) . However, even in animals fed NPD, NiAm injection caused a striking phosphaturia, with no change in Ppi (Table VII) . Injection of NiAm to NPD animals was also associated with an increase in NAD+, and to a lesser degree, an increase in NADH. As in the previous experiment (Table VI) , no changes in the tissue levels of cAMP or ATP were observed after NiAm treatment (Table VII) .
Renal cortical homogenate was fractionated, as de- Tables IV and VI; for details scribed in detail in Methods, to cytosolic fraction (100,000-g supernate) and total particulate fraction (100,000-g pellet), and NAD+ content was determined. The majority of NAD+ (>75%) was found in cytosol (data not shown).
DISCUSSION
Studies in vitro show that NAD added directly to isolated rat renal BBM vesicles inhibits dose-dependently the Na+-dependent 32Pi uptake, and its specificity is underscored by the observation that NAD does not influence D-glucose transport or Na+-independent Pi transport ( Fig. 1 , Table I ). The lack of an effect of NAD on 22Na+ uptake further indicates that inhibition of 32Pi transport is not due to dissipation of the Na+ gradient. NAD inhibits Na+-dependent 32Pi uptake by BBM with similar relative (percent inhibition) effectiveness regardless of whether the rate of Pi transport was enhanced by LPD or lowered by HPD (16) (Table II) . Since NiAm and adenosine added in vitro were without effect on BBM uptake of 32Pi, this observation suggests that NiAm administered in vivo (Fig. 2 , Table VI) did not cause changes in BBM transport of 32Pi by direct action on the BBM. The similarity of in vitro effects of NAD+ and NADH suggests that the action of NAD on BBM uptake of 32Pi may not depend on the redox status of the NAD+/ NADH system. However, it is not precluded that one form of NAD is converted to the other at the BBM, prior to its action on the intramembranous site of the 32Pi uptake mechanism in BBM. Findings that ,-NAD and a-NAD had a similar effect, suggest that NAD action on BBM is not stereospecific (28) , as are some other effects of NAD (11, 12) . Our preliminary experiments show that NAD action does not follow a pattern of competitive inhibition, and that binding of radiolabeled NAD onto BBM is independent ofthe presence of Na+ gradient (31) , suggesting that NAD interaction with BBM may be complex (Kempson and Dousa, unpublished results). Detailed characteristics of NAD interaction with BBM remain to be explored in future systematic studies. Although it is not precluded that nucleotides and coenzymes other than NAD might possibly have a similar effect on BBM transport of Pi when added to BBM in vitro, there presently is no indication-by the nature of their localization in the cell, concentration in the cell, etc.-that other coenzymes play in vivo a similar role to that proposed for NAD.
Most BBM vesicles are oriented rightside-out (32) . Although the intra-membranous site of NAD action on BBM will require systematic examination, some considerations suggest indirectly that NAD acts on the inner portion of the BBM membrane. Sidedness of BBM and its components is presently not amenable to examination in a direct way (32) , but our finding that NAD inhibits AlPase activity located in isolated BBM in a similar way' to NAD inhibition ofthe purified enzyme isolated from the BBM structure (10) (28, 34) and by inhibiting NAD breakdown (21, 28) .
Injection of NiAm in vivo, which increased renal cortical NAD+ (Tables IV, VI , and VII), had effects on BBM virtually identical to the effects of direct NAD addition to BBM in vitro. Na+-dependent BBM uptake of 32Pi was inhibited, but BBM uptake ofD-[3H]glucose, BBM uptake of 22Na+, and the Na+-independent BBM uptake of 32Pi were not changed. The most plausible interpretation of these findings is that the Na+-dependent BBM uptake of 32Pi was inhibited by increased intracellular NAD, namely NAD+, in the cytoplasm of tubular cells. Although the effect of NAD added in vitro on BBM transport resembles effects of changing NAD in vivo, the exact biochemical mechanism of these interactions remains to be determined, and in particular, the causal relationship between changes in NAD+ content and BBM transport of Pi needs to be established.
Some limitations in these experiments should be 1 To ascertain whether NAD inhibits AlPase activity located in the core of BBM (33), as reported for AlPase extracted and purified from pig kidney (10), the effect of NAD on AlPase activity in freshly prepared rat BBM vesicles was tested under conditions similar to those used for measurement of Pi uptake by BBM. Indeed, AlPase activity in BBM in the presence of 300 gM NAD+ (11.9+0.9 umol/h per mg protein was significantly (P < 0.05; n = 3) lower than the activity when no NAD was added (14.9+0.5 ,umol/h per mg protein). NAD not only inhibited AlPase in BBM, but the pattern of the inhibitions in BBM was similar to the reported inhibition of purified isolated AlPase preparations as well (10 (21, 22, 28) and confirmed here for kidney cortex. It is thus likely that our measurements of cortical tissue contents of NAD+ in response to NiAm reflect mostly changes in NAD+ in the cytoplasm of proximal tubular cells.
NiAm administration had no effect on the levels of ATP2 or cAMP in the renal cortex (Tables VI and VII) , two other cellular factors which are currently believed to be involved in proximal tubular transport and its regulation (8, 36) . Although it is realized that ATP levels alone provide limited information about active transport, these results suggest that changes in renal tubular handling of Pi elicited by NiAm administration (Tables IV, V , and VI) are not due to an altered supply of metabolic energy (in the form of ATP) for transport of Pi and are not due to the regulatory effect of intracellular cAMP (37) .
The experiments on rats fed NPD indicate ( (Tables IV-VI) , it is unlikely attributable to extracellular volume expansion or acute acidosis, since LPD rats are resistant to these nonhormonal phosphaturic stimuli (8) . Rats stabilized on LPD are resistant to the phosphaturic effect of PTH (8) . Observations that NiAm causes phosphaturia in TPTX rats fed either NPD (Table VII) or LPD (Table   VI) argue against the possibility that NiAm acted through release of hormones from parathyroid and thyroid tissues, or by sensitizing kidney to endogenous PTH (39) .
The phosphaturic effect of NiAm is very specific for Pi, since no other excretory parameter increased except UpV (Table V) . GFR (6, 38) , and this feature is likely due to the short delay in freezing the tissue (38 (39) . Close correlation between the decrease in Pi uptake by BBM and the increase in UpiV, consequent to NiAm treatment (Fig. 3) , suggests that tubular Pi reabsorption decreases mainly' if not exclusively, in the proximal tubule, the only segment having luminal BBM. However, the present data do not exclude the possibility that NiAm changes Pi reabsorption also in more distal nephron segments. Reversibility of the phosphaturic effect of single injection of NiAm (Table V) seems to be consistent with the expected biochemical mechanism ofNiAm action, since a single injection of NiAm was shown tQ cause transient elevation of the intracellular NAD+ in nonrenal tissues (21, 22, 28) , but the exact time-course of renal effects of NiAm remains to be established. Also, the source of excreted Pi remains to be determined. Since Pp1 did not decrease significantly and UcaV declined (Table V) , these features may suggest indirectly that Pi was mobilized from tissues other than skeleton.
In evaluation of the present findings, it should be realized that correlations and associations between BBM transport parameters, tissue nucleotides, and excretory parameters do not necessarily imply causeeffect relationships; causality in these relationships has to be tested in future studies.
The question arises whether NAD+ could serve in the physiologic control of renal tubular Pi transport. First, it should be emphasized that cytoplasmic pool NAD, rather than mitochondrial NAD, is more likely to regulate BBM uptake of 32Pi in vivo, since the cytoplasmic NAD is accessible for direct contact with BBM. Moreover, NAD+ rather than NADH is likely available for interaction with BBM in vivo. The ratio of free NAD+/free NADH in cytoplasm of renal tissue was indirectly estimated to be more than 100:1 (40), a value much higher than NAD+/NADH ratio in mitochondria (40) or than the NAD+/NADH ratio measured in the whole tissue (30) (Table VI) . NAD+ is much less (about 100 times less) tightly bound to cellular proteins (11, 13, 14) than NADH, which is specifically bound on NADH-dependent cytosolic dehydrogenases (14) . Hence, NAD+ is more available for intracellular shifts and for interaction with BBM.
In considering the potential physiologic role of cytoplasmic NAD+ in regulation of Pi transport, one should recall the following points (Fig. 4) . Some major phosphaturic stimuli, including PTH (acting via cAMP), stimulate gluconeogenesis (GNG) in renal cortex (42) (43) (44) , a metabolic process expected to lead to increased (45, 48) and chronic acidosis by NH4C1 loading (41) . In contrast, GNG may be depressed by feeding LPD (49) . PTH (and other phosphaturic hormones) also enhances the rate of GNG (42, 44) and NAD+ generation via an increase in cAMP, after stimulation of AC, and perhaps by a(tivation of protein kinase (8, 37) . Administration of DBcAMP bypasses hormone-dependent iAMP formation. NiAm administration inoreases NAD+ both by inareasing NAD biosynthesis a22, 28, 34) and by inhibiting NAD+ breakdown (28, 21) by NAD glysohydrolase. Sinse NiAm bypasses all previous tellular steps that influence the NAD+ level, its effect to increase NAD+ inhibits Pi transport aeross BBM regardless of the preeeding status of cell metabolic and regulatory systems, e.g., depressed GNG in LPD rats (49) . generation of cytoplasmic NAD+ from NADH at the glyceraldehyde 3-phosphate dehydrogenase step (45) . The rate of GNG might be due to increased availability of substrates (43) or induction of key enzymes (45) . GNG from pyruvate (47) and several key GNG enzymes are localized only in proximal tubules (48) ; activities of these GNG enzymes are enhanced in acidosis and starvation (48) . This suggests that the potential to enhance NAD+ levels via GNG (46) is limited to proximal tubules. In tubules isolated from LPD rats, the GNG rate was found to be decreased (49) . It is tempting to speculate that lack of a response to PTH (or to DBcAMP) in animals fed LPD (7, 8) may be due to suppressed GNG (49) , and consequently to insufficient generation of cytoplasmic NAD+ needed to inhibit BBM uptake to Pi, in spite of an adequate supply of intracellular or extracellular cAMP. Such an explanation seems to be in agreement with our recent finding (39) which showed that infusion of PTH to rats maintained on NPD caused both phosphaturia and an increase in NAD+/NADH ratio, whereas in rats on LPD, both UpiV and NAD+/NADH ratio failed to increase in the response to PTH (39) . Pretreatment of LPD rats with NiAm, which increased renal cortical NAD+, restored the phosphaturic response to PTH and increase in NAD+/NADH ratio (39) .
In conclusion, based on these multifaceted considerations we propose the hypothesis that NAD, specifically NAD+, serves in the cytoplasm of proximal tubular cells as the final intracellular mediator of some, albeit not necessarily all hormonal and metabolic stimuli that regulate proximal tubular Pi reabsorption, by adjusting the rate of Pi uptake by the luminal BBM as schematically outlined in Fig. 4 . We acknowledge that it remains an open question whether changes in other coenzymes and metabolites linked to NAD (14, 50) play a similar or contributory role in response to the phosphaturic stimuli or in the response to NiAm injection.
Finally, the unique phosphaturic effects of NiAm administration, even in the situation when the kidney is resistant to other phosphaturic stimuli, could be employed in experimental and clinical settings for testing the renal responsiveness, or for restoration of sensitivity (39) to those phosphaturic stimuli, e.g., PTH, which are presumably acting via NAD+.
